Clinical Trials Logo

Clinical Trial Summary

Heparin/Platelet Factor 4 (PF4) antibody testing will be performed in subjects who have just undergone coronary artery bypass grafting (CABG) surgery. 30 subjects with a positive antibody result and no signs or symptoms of Heparin Induced Thrombocytopenia (HIT) will be randomized to receive argatroban and warfarin. 30 subjects with a positive antibody result and no signs or symptoms of HIT will be randomized to receive no treatment. 30 subjects with a negative antibody result will also be followed in the study. All subjects will have a cardiac CT scan at about 30 days post surgery to measure the patency of their coronary artery bypass vein grafts. This study will evaluate if treating patients who have heparin PF4 antibodies post-CABG with argatroban and warfarin has any effect on the short-term patency of coronary artery bypass vein grafts.


Clinical Trial Description

This is a prospective, randomized, single center study. Patients scheduled for CABG will be screened and enrolled. Subjects positive for heparin/PF4 antibody within 24 h after CABG and without clinical suspicion of HIT will be randomized into one of two groups. An additional 30 patients with negative antibody titers will serve as a control group. ;


Study Design


Related Conditions & MeSH terms

  • Coronary Artery Bypass Graft Surgery
  • Presence of Heparin/Platelet Factor 4 Antibody

NCT number NCT01246011
Study type Interventional
Source Massachusetts General Hospital
Contact
Status Terminated
Phase Phase 4
Start date November 2010
Completion date July 2011

See also
  Status Clinical Trial Phase
Completed NCT00248885 - Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG) N/A
Completed NCT04473287 - The Effect of Reflexology After Coronary Artery Bypass Graft Surgery N/A
Completed NCT03892460 - Transitional Rehabilitation in CABG Patients N/A
Completed NCT04238806 - Desflurane,Brain Natriuretic Peptide and Cardiac Surgery N/A
Completed NCT00402506 - A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG Phase 3
Recruiting NCT03900026 - Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery Phase 4
Completed NCT01095419 - Effects of Massage Therapy on Sleep After Heart Surgery N/A
Recruiting NCT05377983 - The Effect of Lavender Oil Inhalation on Pain, Anxiety and Sleep Quality After Coronary Artery Bypass Graft N/A
Completed NCT03123107 - Vitamin C in Cardiac Surgery Patients Phase 1
Terminated NCT00735722 - A(f)MAZE-CABG Study N/A
Recruiting NCT04652375 - Outcomes After Albumin vs Lactated Ringer's Solution in CABG and AVR Procedures N/A
Completed NCT05830682 - Effect of Using Walking Aid on Mobility N/A
Completed NCT05191745 - Long-acting Parasternal Blocks for Analgesia After Cardiac Surgery Phase 3
Enrolling by invitation NCT01127802 - Changes of Functional Status, Symptoms Distress and Quality of Life in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery N/A
Active, not recruiting NCT00396760 - Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery Phase 3
Completed NCT04111744 - Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery N/A
Active, not recruiting NCT01063491 - Cardiac CAtheterization for Bypass Graft Patency Rate Optimization: the CABG-PRO Randomized-controlled Pilot Study Phase 3
Completed NCT00618592 - Does Pre-operative Carbohydrate Loading Reduce Insulin Resistance and Improve Outcomes in Elective Surgical Patients? N/A
Withdrawn NCT04717817 - Inspiratory Muscle Training Prior to Conventional and Minimal Invasive Heart Surgery N/A
Withdrawn NCT00807521 - Steroid-induced Reduction of Surgical Stress Study N/A